응고 분석기 시장 분석 : 검사 유형별, 제품 유형별, 기술 유형별, 최종사용자별, 지역별(2026-2034년)

The global coagulation analyzer market size was valued at USD 6.6 Billion in 2025. Looking forward, IMARC Group estimates the market to reach USD 11.8 Billion by 2034, exhibiting a CAGR of 6.50% from 2026-2034.

Coagulation, also known as hematology, is a process that enables the blood to create a clot to heal a wound. Physicians primarily use coagulation analyzers for quantifying and classifying blood cells. Different types of coagulation tests, such as PT, APTT, ACT, etc., are carried out for assessing blood clotting function in patients. Most of the hematology analyzers are capable of providing information about hemoglobin in red blood cells (RBCs), corpuscular data, platelet counts and hematocrit levels. However, some new machines have been developed to measure two specialized cell types, which include nucleated RBCs and immature white cells. At present, coagulation analyzers are experiencing a rise in their demand on account of consistent growth in the population suffering from blood disorders and lifestyle diseases.

Over the past decade, rapid advancements in technology and the introduction of new coagulation analyzer tests have led to an increase in the quality and efficiency of hemostasis laboratories. Some of the modern complex coagulators also possess high throughput, flexibility and reliability. Other than this, they provide improved accuracy and precision, and easy-to-use advanced software provided with in-built graphs and calibration curves. Moreover, there has been a significant rise in the prevalence of cardiac diseases and blood disorders, which has created the need for improved coagulation analyzers across the globe. Besides this, the sales of coagulation analyzers are positively being influenced by the increasing number of hospitals, diagnostic centers and research institutes established worldwide.

Market Segmentation

This report provides an analysis of the key trends in each sub-segment of the global coagulation analyzer market report, along with forecasts at the global and regional level from 2026-2034. The report has categorized the market based on testing type, product type, technology type and end user.

Breakup by Testing Type

• Prothrombin Time Testing (PT)
• Fibrinogen Testing
• Activated Partial Thromboplastin Time Testing (APTT)
• Activated Clotting Time Testing (ACT)
• D-Dimer Testing
• Platelet Function Testing
• Anti-Factor Xa Testing
• Others

Breakup by Product Type

• Instruments/Analyzers
• Automated Analyzers
• Semi-Automated Analyzers
• Manual Analyzers
• Reagents
• Consumables
• Others

Breakup by Technology Type

• Optical Technology
• Mechanical Technology
• Electrochemical Technology
• Others

Breakup by End User

• Clinical Laboratories
• Diagnostic Centers
• Hospitals
• Others

Breakup by Region

• North America
• Europe
• Asia Pacific
• Middle East and Africa
• Latin America

Competitive Landscape

The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, Roche Diagnostics (F. Hoffmann-La Roche Ltd.), Nihon Kohden, Sysmex Corporation, Siemens Healthineers Company, Thermo Fisher Scientific Inc., Helena Laboratories Corporation, DIAGNOSTICA STAGO, Instrumentation Laboratory Company, etc.

Key Questions Answered in This Report

1. How big is the global coagulation analyzer market?

2. What is the expected growth rate of the global coagulation analyzer market during 2026-2034?

3. What are the key factors driving the global coagulation analyzer market?

4. What has been the impact of COVID-19 on the global coagulation analyzer market?

5. What is the breakup of the global coagulation analyzer market based on the testing type?

6. What is the breakup of the global coagulation analyzer market based on the product type?

7. What is the breakup of the global coagulation analyzer market based on the technology type?

8. What are the key regions in the global coagulation analyzer market?

9. Who are the key players/companies in the global coagulation analyzer market?

Table of Contents

1 Preface

2 Scope and Methodology

• 2.1 Objectives of the Study
• 2.2 Stakeholders
• 2.3 Data Sources
  • 2.3.1 Primary Sources
  • 2.3.2 Secondary Sources
• 2.4 Market Estimation
  • 2.4.1 Bottom-Up Approach
  • 2.4.2 Top-Down Approach
• 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

• 4.1 Overview
• 4.2 Key Industry Trends

5 Global Coagulation Analyzer Market

• 5.1 Market Overview
• 5.2 Market Performance
• 5.3 Impact of COVID-19
• 5.4 Market Breakup by Testing Type
• 5.5 Market Breakup by Product Type
• 5.6 Market Breakup by Technology Type
• 5.7 Market Breakup by End User
• 5.8 Market Breakup by Region
• 5.9 Market Forecast

6 Market Breakup by Testing Type

• 6.1 Prothrombin Time Testing (PT)
  • 6.1.1 Market Trends
  • 6.1.2 Market Forecast
• 6.2 Fibrinogen Testing
  • 6.2.1 Market Trends
  • 6.2.2 Market Forecast
• 6.3 Activated Partial Thromboplastin Time Testing (APTT)
  • 6.3.1 Market Trends
  • 6.3.2 Market Forecast
• 6.4 Activated Clotting Time Testing (ACT)
  • 6.4.1 Market Trends
  • 6.4.2 Market Forecast
• 6.5 D-Dimer Testing
  • 6.5.1 Market Trends
  • 6.5.2 Market Forecast
• 6.6 Platelet Function Testing
  • 6.6.1 Market Trends
  • 6.6.2 Market Forecast
• 6.7 Anti-Factor Xa Testing
  • 6.7.1 Market Trends
  • 6.7.2 Market Forecast
• 6.8 Others
  • 6.8.1 Market Trends
  • 6.8.2 Market Forecast

7 Market Breakup by Product Type

• 7.1 Instruments/Analyzers
  • 7.1.1 Market Trends
  • 7.1.2 Market Breakup by Type
    • 7.1.2.1 Automated Analyzers
    • 7.1.2.2 Semi-Automated Analyzers
    • 7.1.2.3 Manual Analyzers
  • 7.1.3 Market Forecast
• 7.2 Reagents
  • 7.2.1 Market Trends
  • 7.2.2 Market Forecast
• 7.3 Consumables
  • 7.3.1 Market Trends
  • 7.3.2 Market Forecast
• 7.4 Others
  • 7.4.1 Market Trends
  • 7.4.2 Market Forecast

8 Market Breakup by Technology Type

• 8.1 Optical Technology
  • 8.1.1 Market Trends
  • 8.1.2 Market Forecast
• 8.2 Mechanical Technology
  • 8.2.1 Market Trends
  • 8.2.2 Market Forecast
• 8.3 Electrochemical Technology
  • 8.3.1 Market Trends
  • 8.3.2 Market Forecast
• 8.4 Others
  • 8.4.1 Market Trends
  • 8.4.2 Market Forecast

9 Market Breakup by End User

• 9.1 Clinical Laboratories
  • 9.1.1 Market Trends
  • 9.1.2 Market Forecast
• 9.2 Diagnostic Centers
  • 9.2.1 Market Trends
  • 9.2.2 Market Forecast
• 9.3 Hospitals
  • 9.3.1 Market Trends
  • 9.3.2 Market Forecast
• 9.4 Others
  • 9.4.1 Market Trends
  • 9.4.2 Market Forecast

10 Market Breakup by Region

• 10.1 North America
  • 10.1.1 Market Trends
  • 10.1.2 Market Forecast
• 10.2 Europe
  • 10.2.1 Market Trends
  • 10.2.2 Market Forecast
• 10.3 Asia Pacific
  • 10.3.1 Market Trends
  • 10.3.2 Market Forecast
• 10.4 Middle East and Africa
  • 10.4.1 Market Trends
  • 10.4.2 Market Forecast
• 10.5 Latin America
  • 10.5.1 Market Trends
  • 10.5.2 Market Forecast

11 SWOT Analysis

• 11.1 Overview
• 11.2 Strengths
• 11.3 Weaknesses
• 11.4 Opportunities
• 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

• 13.1 Overview
• 13.2 Bargaining Power of Buyers
• 13.3 Bargaining Power of Suppliers
• 13.4 Degree of Competition
• 13.5 Threat of New Entrants
• 13.6 Threat of Substitutes

14 Price Analysis

15 Competitive Landscape

• 15.1 Market Structure
• 15.2 Key Players
• 15.3 Profiles of Key Players
  • 15.3.1 Abbott Laboratories
  • 15.3.2 Roche Diagnostics (F. Hoffmann-La Roche Ltd.)
  • 15.3.3 Nihon Kohden
  • 15.3.4 Sysmex Corporation
  • 15.3.5 Siemens Healthineers Company
  • 15.3.6 Thermo Fisher Scientific Inc.
  • 15.3.7 Helena Laboratories Corporation
  • 15.3.8 DIAGNOSTICA STAGO
  • 15.3.9 Instrumentation Laboratory Company